“Comparison Between Effect of Glimepiride and Pioglitazone on the C-Reactive Protein Level of Type 2 Diabetic Patient”, J. Medicine, vol. 12, no. 1, pp. 30–33, Jan. 2011, doi: 10.3329/jom.v12i1.6929.